InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by York Michael, Vice-Président. Insider active across 3 companies, notably PhaseBio Pharmaceuticals Inc. Aggregated, 3 disclosures have been recorded. The latest transaction was disclosed on 27 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
0210,553 shares0
Common Stock
SEC:0001209191-22-014077:0·
€6,6352,897 shares@ €2.2903100.0% of flow
Common Stock
SEC:0001169245-21-000044·
€6,6352,897 shares@ €2.290350.0% of flow
Common Stock
SEC:0001169245-21-000044:0·
3 of 3 declarations
About York Michael
Michael York is the Vice President of Corporate Development and Chief Business Officer at PhaseBio Pharmaceuticals Inc and Metacrine, Inc. He plays a key role in business development strategy and activity expansion. His expertise contributes to the growth and innovation of the companies.
